Inhibition of lysine63 ubiquitination prevents in vitro and in vivo the progression of renal fibrosis in diabetic nephropathy

被引：0
|
作者：
Pontrelli, P. [1 ]
Menghini, R. [2 ]
Conserva, F. [1 ]
Casagrande, V. [2 ]
Rossini, M. [1 ]
Stasi, A. [1 ]
Divella, C. [1 ]
Cinefra, C. [1 ]
Simone, S. [1 ]
Pertosa, G. [1 ]
Gallone, A. [3 ]
Federici, M. [2 ]
Gesualdo, L. [1 ]
机构：
[1] Univ Bari Aldo Moro, Dept Emergency & Organ Transplantat, Bari, Italy
[2] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy
[3] Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy
来源：
DIABETOLOGIA | 2020年 / 63卷 / SUPPL 1期
基金：
欧盟地平线“2020”;
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
137
引用
收藏
页码：S69 / S69
页数：1
相关论文
共 50 条
  • [41] Connexin 43 prevents the progression of diabetic renal tubulointerstitial fibrosis by regulating the SIRT1-HIF-1α signaling pathway
    Sun, Xiaohong
    Huang, Kaipeng
    Haiming, Xiao
    Lin, Zeyuan
    Yang, Yan
    Zhang, Meng
    Liu, Peiqing
    Huang, Heqing
    CLINICAL SCIENCE, 2020, 134 (13) : 1573 - 1592
  • [42] HYPERGLYCEMIA STIMULATES UBIQUITIN-CONJUGATING ENZYME E2 VARIANT 1 (UBE2V1) MEDIATED LYSINE 63 UBIQUITINATION IN DIABETIC NEPHROPATHY (DN)
    Pontrelli, Paola
    Conserva, Francesca
    Accetturo, Matteo
    Papale, Massimo
    Di Palma, Anna Maria
    Cordisco, Giorgia
    Grandaliano, G.
    Gesualdo, Loreto
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 173 - 173
  • [43] SRT1720 retards renal fibrosis via inhibition of HIF1A/GLUT1 in diabetic nephropathy
    Han, Weixia
    Wang, Chen
    Yang, Zhifen
    Mu, Lin
    Wu, Ming
    Chen, Nan
    Du, Chunyang
    Duan, Huijun
    Shi, Yonghong
    JOURNAL OF ENDOCRINOLOGY, 2019, 241 (01) : 85 - 98
  • [44] Interleukin-22 ameliorated renal injury and fibrosis in diabetic nephropathy through inhibition of NLRP3 inflammasome activation
    Shaofei Wang
    Yubin Li
    Jiajun Fan
    Xuyao Zhang
    Jingyun Luan
    Qi Bian
    Tao Ding
    Yichen Wang
    Ziyu Wang
    Ping Song
    Daxiang Cui
    Xiaobin Mei
    Dianwen Ju
    Cell Death & Disease, 2017, 8 : e2937 - e2937
  • [45] Interleukin-22 ameliorated renal injury and fibrosis in diabetic nephropathy through inhibition of NLRP3 inflammasome activation
    Wang, Shaofei
    Li, Yubin
    Fan, Jiajun
    Zhang, Xuyao
    Luan, Jingyun
    Bian, Qi
    Ding, Tao
    Wang, Yichen
    Wang, Ziyu
    Song, Ping
    Cui, Daxiang
    Mei, Xiaobin
    Ju, Dianwen
    CELL DEATH & DISEASE, 2017, 8 : e2937 - e2937
  • [46] Inhibition of high glucose-induced inflammation and fibrosis by a novel curcumin derivative prevents renal and heart injury in diabetic mice
    Chen, Hongjin
    Yang, Xi
    Lu, Kongqin
    Lu, Chun
    Zhao, Yunjie
    Zheng, Suqing
    Li, Jieli
    Huang, Zhangjian
    Huang, Yi
    Zhang, Yali
    Liang, Guang
    TOXICOLOGY LETTERS, 2017, 278 : 48 - 58
  • [47] Inhibition mechanism of compound ethanol extracts from Wuweizi (Fructus Schisandrae Chinensis) on renal interstitial fibrosis in diabetic nephropathy model mice
    Zhang, Yanqiu
    Zhang, Daning
    Zhang, Mianzhi
    JOURNAL OF TRADITIONAL CHINESE MEDICINE, 2012, 32 (04) : 669 - 673
  • [48] Inhibition mechanism of compound ethanol extracts from Wuweizi(Fructus Schisandrae Chinensis) on renal interstitial fibrosis in diabetic nephropathy model mice
    Yanqiu Zhang
    Daning Zhang
    Mianzhi Zhang
    Journal of Traditional Chinese Medicine, 2012, 32 (04) : 669 - 673
  • [49] ANGPTL2 regulates autophagy through the MEK/ERK/Nrf-1 pathway and affects the progression of renal fibrosis in diabetic nephropathy
    Huang, Haiquan
    Ni, Haifeng
    Ma, Kunling
    Zou, Jihong
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2019, 11 (09): : 5472 - 5486
  • [50] Astragaloside IV Ameliorates Renal Fibrosis via the Inhibition of Mitogen-Activated Protein Kinases and Antiapoptosis In Vivo and In Vitro
    Xu, Weijia
    Shao, Xinghua
    Tian, Lei
    Gu, Leyi
    Zhang, Minfang
    Wang, Qin
    Wu, Bei
    Wang, Ling
    Yao, Jufang
    Xu, Xiaoping
    Mou, Shan
    Ni, Zhaohui
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2014, 350 (03): : 552 - 562
12345